NCT00209417View on ClinicalTrials.gov

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

PHASE4TerminatedINTERVENTIONAL
Enrollment

656

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2011

Study Completion Date

July 31, 2011

Conditions
Renal InsufficiencyDiabetes Mellitus
Interventions
DRUG

Iodixanol 320-Arm 1

DRUG

Iopamidol 300-Arm 2

Trial Locations (2)

08540

GE Healthcare, Princeton

HP7 9LL

GE Healthcare, Amersham

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
collaborator

ABX CRO

OTHER

collaborator

Examination Management Services Inc.

INDUSTRY

collaborator

Covance

INDUSTRY

collaborator

Quintiles, Inc.

INDUSTRY

collaborator

Averion International Corporation

INDUSTRY

lead

GE Healthcare

INDUSTRY

NCT00209417 - Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography | Biotech Hunter | Biotech Hunter